NCT05228015 2024-11-18Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid TumorsIkena OncologyPhase 1 Terminated67 enrolled
NCT06452160 2024-08-09A Study of BGC515 Capsules in Subjects With Advanced Solid TumorsBridGene Biosciences Inc.Phase 1 Recruiting103 enrolled